Richardson, TX – May 21, 2026 – The FDA approved IMMGOLIS and IMMGOLIS INTRI on May 15, 2026. These are the first biosimilars of Johnson & Johnson’s Simponi and Simponi Aria. They have been manufactured by Bio-Thera Solutions and marketed in the U.S. by Accord BioPharma. These interchangeable biosimilars offer new options for adults with […]
